CH554874A - Verfahren zur herstellung von gegen die marek'sche krankheit nuetzliche sulfanilylphenylharnstoff-komplexverbindungen. - Google Patents
Verfahren zur herstellung von gegen die marek'sche krankheit nuetzliche sulfanilylphenylharnstoff-komplexverbindungen.Info
- Publication number
- CH554874A CH554874A CH588171A CH588171A CH554874A CH 554874 A CH554874 A CH 554874A CH 588171 A CH588171 A CH 588171A CH 588171 A CH588171 A CH 588171A CH 554874 A CH554874 A CH 554874A
- Authority
- CH
- Switzerland
- Prior art keywords
- sulphanilylphenylura
- disease
- preparation
- useful against
- complexes useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3102570A | 1970-04-22 | 1970-04-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH554874A true CH554874A (de) | 1974-10-15 |
Family
ID=21857254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH588171A CH554874A (de) | 1970-04-22 | 1971-04-22 | Verfahren zur herstellung von gegen die marek'sche krankheit nuetzliche sulfanilylphenylharnstoff-komplexverbindungen. |
Country Status (9)
Country | Link |
---|---|
US (1) | US3717623A (xx) |
BE (1) | BE766072A (xx) |
CA (1) | CA951726A (xx) |
CH (1) | CH554874A (xx) |
DE (1) | DE2119451A1 (xx) |
FR (1) | FR2092072B1 (xx) |
GB (1) | GB1311618A (xx) |
NL (1) | NL7104785A (xx) |
ZA (1) | ZA712566B (xx) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3960955A (en) * | 1974-11-15 | 1976-06-01 | Texaco Inc. | Purification process |
US3998853A (en) * | 1975-12-04 | 1976-12-21 | Phillips Petroleum Company | 13-Oxatetracyclo[8.2.12,9.0.03,8 ]tridec-5-ene-1,5,6,10-tetracarbonitrile |
US4338334A (en) * | 1977-12-29 | 1982-07-06 | Merck & Co., Inc. | 1-[4-(4-Sulfanilyl)phenyl] urea and derivatives in compositions and methods of treating rheumatoid arthritis and immune complex diseases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2328548A (en) * | 1939-05-27 | 1943-09-07 | Schering Corp | Therapeutically valuable derivative of sulfones |
GB987252A (en) * | 1960-08-29 | 1965-03-24 | Monsanto Canada Ltd | Bacteriostatic adducts of pyridine and pyrimidine derivatives |
-
1970
- 1970-04-22 US US00031025A patent/US3717623A/en not_active Expired - Lifetime
-
1971
- 1971-04-08 NL NL7104785A patent/NL7104785A/xx unknown
- 1971-04-14 CA CA110,352,A patent/CA951726A/en not_active Expired
- 1971-04-19 GB GB979771*[A patent/GB1311618A/en not_active Expired
- 1971-04-21 BE BE766072A patent/BE766072A/xx unknown
- 1971-04-21 FR FR7114169A patent/FR2092072B1/fr not_active Expired
- 1971-04-21 DE DE19712119451 patent/DE2119451A1/de active Pending
- 1971-04-21 ZA ZA712566A patent/ZA712566B/xx unknown
- 1971-04-22 CH CH588171A patent/CH554874A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FR2092072A1 (xx) | 1972-01-21 |
DE2119451A1 (de) | 1971-11-11 |
FR2092072B1 (xx) | 1974-05-24 |
GB1311618A (en) | 1973-03-28 |
NL7104785A (xx) | 1971-10-26 |
BE766072A (fr) | 1971-10-21 |
US3717623A (en) | 1973-02-20 |
ZA712566B (en) | 1972-12-27 |
CA951726A (en) | 1974-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH553780A (de) | Verfahren zur herstellung von neuen 1,4-dihydropyridinderivaten. | |
AT315856B (de) | Verfahren zur herstellung von neuen 4-hydroxy-6-aryl-bzw.6-heteroarylpyrimidinen | |
CH551979A (de) | Verfahren zur herstellung von 1,2-dihydropyrimidinen. | |
AT319948B (de) | Verfahren zur Herstellung von neuen 2,4-Diamino-5-benzylpyrimidinen | |
AT317421B (de) | Verfahren zur Herstellung von Lebendvirus-Impfstoff gegen die Marek'sche Krankheit | |
AT312606B (de) | Verfahren zur Herstellung von neuen 2,2-Diaryl-4-piperidinbutyramiden | |
AT310953B (de) | Verfahren zur Herstellung von neuen 8,9-Didehydro-10-alkoxyergolenderivaten | |
AT299968B (de) | Verfahren zur Herstellung von neuen 5-Imino-1,2,4-triazin-Derivaten | |
CH554874A (de) | Verfahren zur herstellung von gegen die marek'sche krankheit nuetzliche sulfanilylphenylharnstoff-komplexverbindungen. | |
AT310140B (de) | Verfahren zur Herstellung von 2-Alkyl-2-(3'-oxoalkyl)-cycloalkan-1,3-dionen | |
CH556352A (de) | Verfahren zur herstellung von 2-acylamino-1,3,4-thiadiazol-(thi)onen-(5). | |
AT320846B (de) | Verfahren zur Herstellung des neuen 3',4'-Dideoxykanamycins B | |
CH555332A (de) | Verfahren zur herstellung von neuen 1,3,3-trisubstituierten 3-azolylpropinen. | |
CH546730A (de) | Verfahren zur herstellung von n,n'-bis-trifluormethyl-tetrafluoraethylendiamin. | |
AT315142B (de) | Verfahren zur Herstellung von neuen 2-(3'-Oxoalkyl)-cycloalkan-1,3-dionen | |
AT300792B (de) | Verfahren zur Herstellung von neuen modifizierten N,N'substituierten 2,4,5-Triketoimidazolidinen | |
CH557825A (de) | Verfahren zur herstellung von 2,3-dihydrobenzodiazepinen. | |
AT304771B (de) | Verfahren zur Herstellung von neuen Pyranosiden von 3β-Hydroxy-4-chlor-carda-4,20(22)-dienoliden | |
AT306252B (de) | Verfahren zur Herstellung von neuen 2,3-Alkylidenrhamnopyranosiden | |
AT299946B (de) | Verfahren zur Herstellung von neuen 1,3-Benzodioxol-2-thionen | |
CH555330A (de) | Verfahren zur herstellung pharmazeutisch wertvoller 1,4benzodioxane. | |
CH552621A (de) | Verfahren zur herstellung von 4-(5'-nitrofurfurylidenamino)-octahydro-4h-1,4-benzthiazin-1,1-dioxid. | |
AT302504B (de) | Verfahren zur Herstellung von neuen 1:1- bzw. 1:2-Schwermetallkomplexen | |
AT309708B (de) | Verfahren zur Herstellung des neuen 1,2α-Methylen-6,7α-difluormethylen-20-spirox-4-en-3-on | |
AT308749B (de) | Verfahren zur Herstellung von 3,5-Dialkylpyridinen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |